Merck
We Help Cattle Grow

The science behind Revalor®-XR

Proprietary delayed and extended release technology delivers trenbolone acetate and estradiol in a unique way.

Revalor XR

Designed for steers or heifers fed in confinement, Revalor®-XR delivers the combination of trenbolone acetate and estradiol of a performance-based terminal implant in a single administration, thanks to its unique, delayed and extended release technology.

Each Revalor®-XR implant consists of 10 small pellets

  • All ten pellets are coated with a patented polymer. This creates a delayed and extended release product that takes effect 70 days after implanting, providing the benefits of a performance based terminal implant without the hassle of re-handling.
     

 

Revalor XH
End section - Uncoated (25x)
  Revalor XH
End section - Coated (25x)

Microscopic view of coated and uncoated pellets

  • Revalor®-XR contains trenbolone acetate and estradiol in a 10:1 ratio.

  • Each coated pellet contains 20 mg of trenbolone acetate and 2 mg of estradiol, for a total dose of 200 mg of trenbolone acetate and 20 mg of estradiol.

REVALOR® is a registered trademark of Intervet International B.V. Used under license.